Copyright Reports & Markets. All rights reserved.

Global Abdominal Aortic Aneurysm Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Abdominal Aortic Aneurysm Drug

      • 1.1 Definition of Abdominal Aortic Aneurysm Drug
      • 1.2 Abdominal Aortic Aneurysm Drug Segment by Type
        • 1.2.1 Global Abdominal Aortic Aneurysm Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BSN-908
        • 1.2.3 Canakinumab
        • 1.2.4 CT-2009
        • 1.2.5 Ticagrelor
        • 1.2.6 Others
      • 1.3 Abdominal Aortic Aneurysm Drug Segment by Applications
        • 1.3.1 Global Abdominal Aortic Aneurysm Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Abdominal Aortic Aneurysm Drug Overall Market
        • 1.4.1 Global Abdominal Aortic Aneurysm Drug Revenue (2014-2025)
        • 1.4.2 Global Abdominal Aortic Aneurysm Drug Production (2014-2025)
        • 1.4.3 North America Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)
        • 1.4.5 China Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)
        • 1.4.8 India Abdominal Aortic Aneurysm Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Abdominal Aortic Aneurysm Drug
      • 2.3 Manufacturing Process Analysis of Abdominal Aortic Aneurysm Drug
      • 2.4 Industry Chain Structure of Abdominal Aortic Aneurysm Drug

      3 Development and Manufacturing Plants Analysis of Abdominal Aortic Aneurysm Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Abdominal Aortic Aneurysm Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Abdominal Aortic Aneurysm Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Abdominal Aortic Aneurysm Drug Production and Capacity Analysis
      • 4.2 Abdominal Aortic Aneurysm Drug Revenue Analysis
      • 4.3 Abdominal Aortic Aneurysm Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Abdominal Aortic Aneurysm Drug Regional Market Analysis

      • 5.1 Abdominal Aortic Aneurysm Drug Production by Regions
        • 5.1.1 Global Abdominal Aortic Aneurysm Drug Production by Regions
        • 5.1.2 Global Abdominal Aortic Aneurysm Drug Revenue by Regions
      • 5.2 Abdominal Aortic Aneurysm Drug Consumption by Regions
      • 5.3 North America Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.3.1 North America Abdominal Aortic Aneurysm Drug Production
        • 5.3.2 North America Abdominal Aortic Aneurysm Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Abdominal Aortic Aneurysm Drug Import and Export
      • 5.4 Europe Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.4.1 Europe Abdominal Aortic Aneurysm Drug Production
        • 5.4.2 Europe Abdominal Aortic Aneurysm Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Abdominal Aortic Aneurysm Drug Import and Export
      • 5.5 China Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.5.1 China Abdominal Aortic Aneurysm Drug Production
        • 5.5.2 China Abdominal Aortic Aneurysm Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Abdominal Aortic Aneurysm Drug Import and Export
      • 5.6 Japan Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.6.1 Japan Abdominal Aortic Aneurysm Drug Production
        • 5.6.2 Japan Abdominal Aortic Aneurysm Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Abdominal Aortic Aneurysm Drug Import and Export
      • 5.7 Southeast Asia Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.7.1 Southeast Asia Abdominal Aortic Aneurysm Drug Production
        • 5.7.2 Southeast Asia Abdominal Aortic Aneurysm Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Abdominal Aortic Aneurysm Drug Import and Export
      • 5.8 India Abdominal Aortic Aneurysm Drug Market Analysis
        • 5.8.1 India Abdominal Aortic Aneurysm Drug Production
        • 5.8.2 India Abdominal Aortic Aneurysm Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Abdominal Aortic Aneurysm Drug Import and Export

      6 Abdominal Aortic Aneurysm Drug Segment Market Analysis (by Type)

      • 6.1 Global Abdominal Aortic Aneurysm Drug Production by Type
      • 6.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type
      • 6.3 Abdominal Aortic Aneurysm Drug Price by Type

      7 Abdominal Aortic Aneurysm Drug Segment Market Analysis (by Application)

      • 7.1 Global Abdominal Aortic Aneurysm Drug Consumption by Application
      • 7.2 Global Abdominal Aortic Aneurysm Drug Consumption Market Share by Application (2014-2019)

      8 Abdominal Aortic Aneurysm Drug Major Manufacturers Analysis

      • 8.1 AstraZeneca Plc
        • 8.1.1 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Production Sites and Area Served
        • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.1.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Carolus Therapeutics, Inc.
        • 8.2.1 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Production Sites and Area Served
        • 8.2.2 Carolus Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.2.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Novartis AG
        • 8.3.1 Novartis AG Abdominal Aortic Aneurysm Drug Production Sites and Area Served
        • 8.3.2 Novartis AG Product Introduction, Application and Specification
        • 8.3.3 Novartis AG Abdominal Aortic Aneurysm Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Vida Therapeutics Inc.
        • 8.4.1 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Production Sites and Area Served
        • 8.4.2 Vida Therapeutics Inc. Product Introduction, Application and Specification
        • 8.4.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served

      9 Development Trend of Analysis of Abdominal Aortic Aneurysm Drug Market

      • 9.1 Global Abdominal Aortic Aneurysm Drug Market Trend Analysis
        • 9.1.1 Global Abdominal Aortic Aneurysm Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Abdominal Aortic Aneurysm Drug Regional Market Trend
        • 9.2.1 North America Abdominal Aortic Aneurysm Drug Forecast 2019-2025
        • 9.2.2 Europe Abdominal Aortic Aneurysm Drug Forecast 2019-2025
        • 9.2.3 China Abdominal Aortic Aneurysm Drug Forecast 2019-2025
        • 9.2.4 Japan Abdominal Aortic Aneurysm Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Abdominal Aortic Aneurysm Drug Forecast 2019-2025
        • 9.2.6 India Abdominal Aortic Aneurysm Drug Forecast 2019-2025
      • 9.3 Abdominal Aortic Aneurysm Drug Market Trend (Product Type)
      • 9.4 Abdominal Aortic Aneurysm Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Abdominal Aortic Aneurysm Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Abdominal Aortic Aneurysm Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Abdominal Aortic Aneurysm Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Abdominal Aortic Aneurysm Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Abdominal Aortic Aneurysm Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Abdominal Aortic Aneurysm Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AstraZeneca Plc
        Carolus Therapeutics, Inc.
        Novartis AG
        Vida Therapeutics Inc.
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        BSN-908
        Canakinumab
        CT-2009
        Ticagrelor
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now